BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31639434)

  • 1. Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases.
    Ruiz-Gaspà S; Guañabens N; Jurado S; Dubreuil M; Combalia A; Peris P; Monegal A; Parés A
    Gene; 2020 Jan; 725():144167. PubMed ID: 31639434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis.
    Ruiz-Gaspà S; Dubreuil M; Guañabens N; Combalia A; Peris P; Monegal A; Parés A
    Eur J Clin Invest; 2014 Dec; 44(12):1206-14. PubMed ID: 25331234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells.
    Dubreuil M; Ruiz-Gaspà S; Guañabens N; Peris P; Alvarez L; Monegal A; Combalia A; Parés A
    Liver Int; 2013 Aug; 33(7):1029-38. PubMed ID: 23560764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilirubin and bile acids in osteocytes and bone tissue. Potential role in the cholestatic-induced osteoporosis.
    Ruiz-Gaspà S; Guañabens N; Jurado S; Combalia A; Peris P; Monegal A; Parés A
    Liver Int; 2020 Nov; 40(11):2767-2775. PubMed ID: 32749754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithocholic acid downregulates vitamin D effects in human osteoblasts.
    Ruiz-Gaspà S; Guañabens N; Enjuanes A; Peris P; Martinez-Ferrer A; de Osaba MJ; Gonzalez B; Alvarez L; Monegal A; Combalia A; Parés A
    Eur J Clin Invest; 2010 Jan; 40(1):25-34. PubMed ID: 20055894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilirubin increases viability and decreases osteoclast apoptosis contributing to osteoporosis in advanced liver diseases.
    Jurado S; Parés A; Peris P; Combalia A; Monegal A; Guañabens N
    Bone; 2022 Sep; 162():116483. PubMed ID: 35787483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bilirubin and sera from jaundiced patients on osteoblasts: contribution to the development of osteoporosis in liver diseases.
    Ruiz-Gaspà S; Martinez-Ferrer A; Guañabens N; Dubreuil M; Peris P; Enjuanes A; Martinez de Osaba MJ; Alvarez L; Monegal A; Combalia A; Parés A
    Hepatology; 2011 Dec; 54(6):2104-13. PubMed ID: 21837749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid.
    Thérien A; Cieślak A; Verreault M; Perreault M; Trottier J; Gobeil S; Vohl MC; Barbier O
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
    Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
    Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver.
    Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Pojer C; Zenz R; Lammert F; Stieger B; Meier PJ; Zatloukal K; Denk H; Trauner M
    Gastroenterology; 2001 Jul; 121(1):170-83. PubMed ID: 11438506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).
    Chazouillères O; Marteau P; Haniche M; Jian R; Poupon R
    Dig Dis Sci; 1996 Dec; 41(12):2417-22. PubMed ID: 9011452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
    Ward JBJ; Lajczak NK; Kelly OB; O'Dwyer AM; Giddam AK; Ní Gabhann J; Franco P; Tambuwala MM; Jefferies CA; Keely S; Roda A; Keely SJ
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G550-G558. PubMed ID: 28360029
    [No Abstract]   [Full Text] [Related]  

  • 13. The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis.
    Lajczak-McGinley NK; Porru E; Fallon CM; Smyth J; Curley C; McCarron PA; Tambuwala MM; Roda A; Keely SJ
    Physiol Rep; 2020 Jun; 8(12):e14456. PubMed ID: 32562381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
    Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
    Purucker E; Marschall HU; Winograd R; Matern S
    Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
    Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
    Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis in chronic liver disease.
    Guañabens N; Parés A
    Liver Int; 2018 May; 38(5):776-785. PubMed ID: 29479832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cholestasis on absorption of ursodeoxycholic acid.
    Sauer P; Benz C; Rudolph G; Klöters-Plachky P; Stremmel W; Stiehl A
    Dig Dis Sci; 1999 Apr; 44(4):817-22. PubMed ID: 10219843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases.
    Festi D; Montagnani M; Azzaroli F; Lodato F; Mazzella G; Roda A; Di Biase AR; Roda E; Simoni P; Colecchia A
    Curr Clin Pharmacol; 2007 May; 2(2):155-77. PubMed ID: 18690863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice.
    Fickert P; Fuchsbichler A; Marschall HU; Wagner M; Zollner G; Krause R; Zatloukal K; Jaeschke H; Denk H; Trauner M
    Am J Pathol; 2006 Feb; 168(2):410-22. PubMed ID: 16436656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.